301 related articles for article (PubMed ID: 28465626)
1. Synthesis and biological evaluation of indole core-based derivatives with potent antibacterial activity against resistant bacterial pathogens.
Hong W; Li J; Chang Z; Tan X; Yang H; Ouyang Y; Yang Y; Kaur S; Paterson IC; Ngeow YF; Wang H
J Antibiot (Tokyo); 2017 Jul; 70(7):832-844. PubMed ID: 28465626
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationship of novel bisindole amidines active against MDR Gram-positive and Gram-negative bacteria.
Liu Y; Hu X; Wu Y; Zhang W; Chen X; You X; Hu L
Eur J Med Chem; 2018 Apr; 150():771-782. PubMed ID: 29604581
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antibacterial activity of substituted 1,2,3,4-tetrahydropyrazino [1,2-a] indoles.
Tiwari RK; Singh D; Singh J; Yadav V; Pathak AK; Dabur R; Chhillar AK; Singh R; Sharma GL; Chandra R; Verma AK
Bioorg Med Chem Lett; 2006 Jan; 16(2):413-6. PubMed ID: 16246547
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antibacterial bioactivities of cationic deacetyl linezolid amphiphiles.
Bai PY; Qin SS; Chu WC; Yang Y; Cui DY; Hua YG; Yang QQ; Zhang E
Eur J Med Chem; 2018 Jul; 155():925-945. PubMed ID: 29966917
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro activity of dicationic indolyl diphenyl ethers as novel potent antibiotic agents against drug-resistant bacteria.
Chen X; Hu X; Wu Y; Liu Y; Bian C; Nie T; You X; Hu L
Bioorg Med Chem Lett; 2017 Feb; 27(4):841-844. PubMed ID: 28109787
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem.
Koga T; Abe T; Inoue H; Takenouchi T; Kitayama A; Yoshida T; Masuda N; Sugihara C; Kakuta M; Nakagawa M; Shibayama T; Matsushita Y; Hirota T; Ohya S; Utsui Y; Fukuoka T; Kuwahara S
Antimicrob Agents Chemother; 2005 Aug; 49(8):3239-50. PubMed ID: 16048932
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of tigecycline against multiple-drug-resistant, including pan-resistant, gram-negative and gram-positive clinical isolates from Greek hospitals.
Souli M; Kontopidou FV; Koratzanis E; Antoniadou A; Giannitsioti E; Evangelopoulou P; Kannavaki S; Giamarellou H
Antimicrob Agents Chemother; 2006 Sep; 50(9):3166-9. PubMed ID: 16940120
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel deoxyribofuranosyl indole antimicrobial agents.
Paudel A; Hamamoto H; Kobayashi Y; Yokoshima S; Fukuyama T; Sekimizu K
J Antibiot (Tokyo); 2012 Feb; 65(2):53-7. PubMed ID: 22167161
[TBL] [Abstract][Full Text] [Related]
9. Bactericidal activity and mechanism of action of copper-sputtered flexible surfaces against multidrug-resistant pathogens.
Ballo MK; Rtimi S; Mancini S; Kiwi J; Pulgarin C; Entenza JM; Bizzini A
Appl Microbiol Biotechnol; 2016 Jul; 100(13):5945-53. PubMed ID: 27020284
[TBL] [Abstract][Full Text] [Related]
10. Novel cajaninstilbene acid derivatives as antibacterial agents.
Geng ZZ; Zhang JJ; Lin J; Huang MY; An LK; Zhang HB; Sun PH; Ye WC; Chen WM
Eur J Med Chem; 2015 Jul; 100():235-45. PubMed ID: 26093280
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationship of amidine derivatives of 3,4-ethylenedioxythiophene as novel antibacterial agents.
Stolić I; Čipčić Paljetak H; Perić M; Matijašić M; Stepanić V; Verbanac D; Bajić M
Eur J Med Chem; 2015 Jan; 90():68-81. PubMed ID: 25461312
[TBL] [Abstract][Full Text] [Related]
12. Cationic compounds with activity against multidrug-resistant bacteria: interest of a new compound compared with two older antiseptics, hexamidine and chlorhexidine.
Grare M; Dibama HM; Lafosse S; Ribon A; Mourer M; Regnouf-de-Vains JB; Finance C; Duval RE
Clin Microbiol Infect; 2010 May; 16(5):432-8. PubMed ID: 19456831
[TBL] [Abstract][Full Text] [Related]
13. Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
Hossion AM; Zamami Y; Kandahary RK; Tsuchiya T; Ogawa W; Iwado A; Sasaki K
J Med Chem; 2011 Jun; 54(11):3686-703. PubMed ID: 21534606
[TBL] [Abstract][Full Text] [Related]
14. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
Dowzicky MJ; Park CH
Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antibacterial activity of novel (un)substituted benzotriazolyl oxazolidinone derivatives.
Dixit PP; Nair PS; Patil VJ; Jain S; Arora SK; Sinha N
Bioorg Med Chem Lett; 2005 Jun; 15(12):3002-5. PubMed ID: 15908210
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of tigecycline and comparator agents against a global collection of Gram-negative and Gram-positive organisms: tigecycline Evaluation and Surveillance Trial 2004 to 2007.
Garrison MW; Mutters R; Dowzicky MJ
Diagn Microbiol Infect Dis; 2009 Nov; 65(3):288-99. PubMed ID: 19733459
[TBL] [Abstract][Full Text] [Related]
17. [The history of the development and changes of quinolone antibacterial agents].
Takahashi H; Hayakawa I; Akimoto T
Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
[TBL] [Abstract][Full Text] [Related]
18. The β-Lactams Strike Back: Ceftazidime-Avibactam.
Zasowski EJ; Rybak JM; Rybak MJ
Pharmacotherapy; 2015 Aug; 35(8):755-70. PubMed ID: 26289307
[TBL] [Abstract][Full Text] [Related]
19. Tigecycline: first of a new class of antimicrobial agents.
Rose WE; Rybak MJ
Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487
[TBL] [Abstract][Full Text] [Related]
20. 5-O-Mycaminosyltylonolide antibacterial derivatives: design, synthesis and bioactivity.
Sugawara A; Maruyama H; Shibusawa S; Matsui H; Hirose T; Tsutsui A; Froyman R; Ludwig C; Koebberling J; Hanaki H; Kleefeld G; Ōmura S; Sunazuka T
J Antibiot (Tokyo); 2017 Jul; 70(8):878-887. PubMed ID: 28559578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
